1) Reinforcement chemotherapy
强化化疗
2) treatment
[英]['tri:tmənt] [美]['tritmənt]
强化治疗
1.
Anti-inflammatory and anti-myocardial ischemic effects of atorvastatin intensive treatment towards non-ST elevation acute myocardial infraction patients;
阿托伐他汀强化治疗对非ST段抬高急性心肌梗死患者的抗炎、抗心肌缺血作用
2.
Clinical Observe of Atorvastatin Intensive Treatment Towards Acute Coronary Syndrome;
阿托伐他汀强化治疗急性冠脉综合征的临床观察
3) Intensive treatment
强化治疗
1.
Objective To evaluate the effect of 24-h life guidance method on newly diagnosed type 2 diabetic patients subject to insulin intensive treatment.
目的评价24h生活指导对初诊2型糖尿病(T2DM)胰岛素强化治疗患者的干预效果。
2.
Intensive treatment on blood glucose, blood pressure and lipids together with anti-platelet therapy were given.
目的 探讨多因素的强化治疗对于新诊断的 2型糖尿病患者代谢综合征的疗效。
3.
According to the effects of the intensive treatment(Lying in bed completely,sacral anesthesia,mannitol,dexamethasone,Danshen injection intraenous injection,non-sterol antibodies per os)the investigation is made in groups.
方法 对 2 73例病人 ,根据强化治疗 (绝对卧床休息 ,骶管阻滞 ,静滴甘露醇、地塞米松、丹参注射液 ,口服非甾体抗炎药 )后效果进行分组研究。
4) Intensification therapy
强化治疗
1.
Evaluation on effect of applying clinical path practice for intensification therapy of primarily diagnosed type 2 diabetes patients;
对初诊2型糖尿病强化治疗病人应用临床路径实践的效果评价
2.
ConclusionIntensification therapy with insulin glargine and Metformin can reach controlling standard and excellent curative effect in short-term.
目的:观察甘清胰岛素联合二甲双胍强化治疗在2型糖尿病的临床疗效。
3.
Conclusion Repeated intensification therapy including the induction regimen for AML can result in better efficacy than the alternate of multi-regimen.
目的:探讨急性髓系白血病(AML)诱导缓解后的适宜强化治疗方案。
5) Intensive Therapy
强化治疗
1.
Effect of early insulin intensive therapy on β cell function & study of the different ISF in different periods and correlation between ISF and CP/FBG in children with type 1 diabetes mellitus;
早期强化治疗儿童TⅠDM对β细胞功能的影响及ISF与C-P/FBG相关性研究
2.
Application of glargine in intensive therapy of type 2 diabetes mellitus;
甘精胰岛素在2型糖尿病强化治疗中的应用
3.
Methods 23 AML patients were treated by the ID Are-C chemotherapy, 15 patients were for postrem ission intensive therapy, 8 patients with refractory or relapsed AML were for induction therapy.
方法用IDAra-C对23例AML患者进行化疗,其中用于完全缓解(CR)后强化治疗15例,用于难治性复发性AML诱导缓解治疗8例。
补充资料：恶性滋养细胞肿瘤终止化疗的指征
恶性滋养细胞肿瘤终止化疗的指征
恶性滋养细胞肿瘤经过化疗后，由于目前尚无很好方法测出体内有无残存瘤细胞、HCG放射免疫测定虽然比较灵敏，但也很难达到查出少量残存瘤细胞的目的，为此，治疗持续到达临床完全恢复的标准(即肺及子宫内转移灶完全消失，血或尿内HCG正常，临床无症状)，还需再巩固1～2个疗程，方可停药观察，病情无变化才能出院，以后继续随访。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条